FDA Guidance on Covariate Adjustments: What Non-Statisticians Need to Know

In May 2023 the FDA issued a final guidance on adjusting for covariates in the statistical analysis of randomized clinical trials. Non-statistical team members should read this summary of the general considerations section found in the FDA’s guidance to better understand and support covariate adjustments applied in clinical trials.


Please fill out this form.

Please enable JavaScript in your browser to complete this form.
Please do not enter personal email id like gmail or yahoo